CN101879246A - Traditional Chinese medicine for treating lupus erythematosus - Google Patents

Traditional Chinese medicine for treating lupus erythematosus Download PDF

Info

Publication number
CN101879246A
CN101879246A CN200910083702XA CN200910083702A CN101879246A CN 101879246 A CN101879246 A CN 101879246A CN 200910083702X A CN200910083702X A CN 200910083702XA CN 200910083702 A CN200910083702 A CN 200910083702A CN 101879246 A CN101879246 A CN 101879246A
Authority
CN
China
Prior art keywords
chinese medicine
traditional chinese
lupus erythematosus
fine powder
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200910083702XA
Other languages
Chinese (zh)
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lvyuan Qiuzheng Technology Development Co Ltd
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN200910083702XA priority Critical patent/CN101879246A/en
Publication of CN101879246A publication Critical patent/CN101879246A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine for treating lupus erythematosus, and belongs to the field of traditional Chinese medicines for treating rheumatism. The traditional Chinese medicine aims to have good effect and quick response. The traditional Chinese medicine is prepared from sweet wormwood herb, Chinese angelica, honeysuckle, turtle shell, notoginseng root, rehmanniae praeparatum, glossy ganoderma and the like serving as raw materials, has the effects of strengthening body resistance and archaeus, supplementing qi and nourishing blood, promoting blood circulation by removing blood stasis and clearing heat and cooling blood, and has the advantages of obvious effect, definite curative effect and quick response.

Description

A kind of Chinese medicine for the treatment of lupus erythematosus
Technical field
The invention belongs to the rheumatismal field of Chinese medicines of treatment.
Background technology
At present, be intended to treat the field of Chinese medicines of lupus erythematosus, exist the deficiency of two aspects: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.So that many lupus erythematosus patients can not get the treatment of active drug for a long time, prolonged low grade fever, skin lesion and arthralgia are serious, and usually involve kidney, heart, respiratory system etc., course of disease delay, outbreak repeatedly, patient and family members thereof are very dissatisfied to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of lupus erythematosus, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of lupus erythematosus adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Herba Artemisiae Annuae 2-20 part Radix Angelicae Sinensis 3-30 part Flos Lonicerae 3-30 part
Carapax Trionycis 2-20 part Radix Notoginseng 2-20 part Radix Rehmanniae 3-30 part
Ganoderma 2-20 part
The Chinese medicine of this treatment lupus erythematosus is made by following method:
(1) by above-mentioned weight ratio, Herba Artemisiae Annuae, Radix Angelicae Sinensis, Flos Lonicerae, Carapax Trionycis, the Radix Rehmanniae are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma, Radix Rehmanniae the body resistance strengthening and constitution consolidating, benefiting QI and nourishing blood in the side; Radix Notoginseng, Radix Angelicae Sinensis blood circulation promoting and blood stasis dispelling; 5 with Carapax Trionycis hard masses softening and resolving; The Flos Lonicerae heat-clearing and toxic substances removing; The Herba Artemisiae Annuae removing heat from blood, clearing away deficiency-heat.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, the merit of clearing away heat and cooling blood, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Herba Artemisiae Annuae 30 gram Radix Angelicae Sinensis 40 gram Flos Loniceraes 40 grams
The Carapax Trionycis 30 gram Radix Notoginseng 30 gram Radix Rehmanniae 30 grams
Ganoderma 30 grams
Weight in accordance with regulations, with conventional water extraction process Herba Artemisiae Annuae, Radix Angelicae Sinensis, Flos Lonicerae, Carapax Trionycis, the Radix Rehmanniae are extracted, make extractum fine powder 42.5 grams, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 366 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Herba Artemisiae Annuae 90 gram Radix Angelicae Sinensis 180 gram Flos Loniceraes 180 grams
The Carapax Trionycis 90 gram Radix Notoginseng 90 gram Radix Rehmanniae 180 grams
Ganoderma 90 grams
By above-mentioned same method, make 1286 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Herba Artemisiae Annuae 180 gram Radix Angelicae Sinensis 300 gram Flos Loniceraes 300 grams
The Carapax Trionycis 180 gram Radix Notoginseng 180 gram Radix Rehmanniae 300 grams
Ganoderma 180 grams
By above-mentioned same method, make 2410 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
6 parts of 7 portions of Flos Loniceraes of 4 parts of Radix Angelicae Sinensis of Herba Artemisiae Annuae
7 parts in 5 parts of Radix Rehmanniae of 5 portions of Radix Notoginseng of Carapax Trionycis
4 parts of Ganodermas
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
25 parts of 25 portions of Flos Loniceraes of 18 parts of Radix Angelicae Sinensis of Herba Artemisiae Annuae
25 parts in 18 parts of Radix Rehmanniae of 18 portions of Radix Notoginseng of Carapax Trionycis
18 parts of Ganodermas
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science lupus erythematosus, through 11 routine clinical observations.Selecting the tcm diagnosis lupus erythematosus is standard: prolonged low grade fever; Skin lesion is serious, and the facial and bridge of the nose is butterfly-like distribution erythema; Arthralgia, surrounding tissue swelling; The state of an illness is often involved kidney, heart, respiratory system and digestive system.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 1 example, women's 10 examples do not have other serious disease, and the age is 28 years old-47 years old, 37.2 years old mean age.
Efficacy determination:
1, produce effects: low grade fever disappears, and limbs are strong; Skin lesion is obviously alleviated; Arthralgia alleviates; Kidney, heart, respiratory system and digestive system disease are alleviated to some extent.
2, effective: low grade fever, skin lesion, arthralgia are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 3 times, each 5 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 6 months after, symptom is obviously improved.11 philtrums of clinical experiment, produce effects 6 people, effective 4 people, invalid 1 people, total effective rate 90.9%.

Claims (1)

1. a Chinese medicine for the treatment of lupus erythematosus adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Herba Artemisiae Annuae 2-20 part Radix Angelicae Sinensis 3-30 part Flos Lonicerae 3-30 part
Carapax Trionycis 2-20 part Radix Notoginseng 2-20 part Radix Rehmanniae 3-30 part
Ganoderma 2-20 part
The Chinese medicine of this treatment lupus erythematosus is made by following method:
(1) by above-mentioned weight ratio, Herba Artemisiae Annuae, Radix Angelicae Sinensis, Flos Lonicerae, Carapax Trionycis, the Radix Rehmanniae are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
CN200910083702XA 2009-05-08 2009-05-08 Traditional Chinese medicine for treating lupus erythematosus Pending CN101879246A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200910083702XA CN101879246A (en) 2009-05-08 2009-05-08 Traditional Chinese medicine for treating lupus erythematosus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200910083702XA CN101879246A (en) 2009-05-08 2009-05-08 Traditional Chinese medicine for treating lupus erythematosus

Publications (1)

Publication Number Publication Date
CN101879246A true CN101879246A (en) 2010-11-10

Family

ID=43051475

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200910083702XA Pending CN101879246A (en) 2009-05-08 2009-05-08 Traditional Chinese medicine for treating lupus erythematosus

Country Status (1)

Country Link
CN (1) CN101879246A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202011103697U1 (en) * 2011-07-25 2012-11-15 Ottmar W. Geiger Compositions of the plant Artemisia annua

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202011103697U1 (en) * 2011-07-25 2012-11-15 Ottmar W. Geiger Compositions of the plant Artemisia annua

Similar Documents

Publication Publication Date Title
CN101843787B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843694A (en) Chinese medicament for treating chronic hepatitis
CN101850071B (en) Chinese medicament for treating chronic nephritis
CN101843829B (en) Chinese medicament for treating pulmonary heart diseases
CN101843705B (en) Chinese medicament for treating lupus erythematosus
CN101843718B (en) Chinese medicament for treating lupus erythematosus
CN101850018A (en) Chinese medicament for treating cervical spondylosis
CN101879246A (en) Traditional Chinese medicine for treating lupus erythematosus
CN101843731B (en) Chinese medicament for treating femoral head necrosis
CN101843698B (en) Chinese medicament for treating cervical spondylosis
CN101843707B (en) Chinese medicament for treating chronic hepatitis
CN101843679B (en) Chinese medicament for treating cervical spondylosis
CN101843759B (en) Oral Chinese medicament for treating fracture
CN101843825B (en) Chinese medicament for treating climacteric syndromes
CN101843693A (en) Chinese medicament for treating diabetic nephropathy
CN101843722B (en) Chinese medicament for treating ichthyosis
CN101518622B (en) Traditional Chinese medicine for treating diabetes complicated with urinary infection
CN101843777B (en) Chinese medicament for treating liver cirrhosis
CN101843750B (en) Chinese medicament for treating chronic nephritis
CN101843711B (en) Chinese medicament for treating ichthyosis
CN101843818B (en) Chinese medicament for treating chronic nephritis
CN101843749A (en) Chinese medicament for treating femoral head necrosis
CN101879245A (en) Traditional Chinese medicine for treating femoral head necrosis
CN101843796A (en) Chinese medicament for treating pulmonary heart diseases
CN101843692A (en) Chinese medicament for treating lupus erythematosus

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20101110